Number of the records: 1

ipilimumab

Subject h.	ipilimumab
Subject h.	Ipilimumab
Entry terms	anti-CTLA-4 MAb ipilimumab MDX 010 MDX-CTLA-4
Scope note in English	An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
See also reference (FX) in Slovak	antigén CTLA-4
See also reference (FX) in English	CTLA-4 Antigen
Links	(11) - ARTICLES
	(1) - MeSH descriptor
	(3) - CiBaMed

subject heading

Number of the records: 1